| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6692 |
| Human Intestinal Absorption | HIA+ | 0.9004 |
| Caco-2 Permeability | Caco2- | 0.6516 |
| P-glycoprotein Substrate | Non-substrate | 0.6757 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9646 |
| Non-inhibitor | 0.9843 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9497 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7843 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8227 |
| CYP450 2D6 Substrate | Non-substrate | 0.9331 |
| CYP450 3A4 Substrate | Non-substrate | 0.7247 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9489 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8722 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9392 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9528 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9684 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9701 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9697 |
| Non-inhibitor | 0.9826 |
| AMES Toxicity | Non AMES toxic | 0.8707 |
| Carcinogens | Non-carcinogens | 0.5089 |
| Fish Toxicity | High FHMT | 0.7416 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9910 |
| Honey Bee Toxicity | High HBT | 0.7736 |
| Biodegradation | Ready biodegradable | 0.8690 |
| Acute Oral Toxicity | III | 0.7985 |
| Carcinogenicity (Three-class) | Non-required | 0.6934 |